Pluri (PLUR) EBT (QoQ) (2010 - 2025)
Pluri (PLUR) EBT (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.05% |
| Sep 30, 2025 | 10.42% |
| Jun 30, 2025 | -22.13% |
| Mar 31, 2025 | -80.45% |
| Dec 31, 2024 | 48.48% |
| Sep 30, 2024 | 3.45% |
| Jun 30, 2024 | -5.54% |
| Mar 31, 2024 | -9.12% |
| Dec 31, 2023 | 2.90% |
| Sep 30, 2023 | 6.55% |
| Jun 30, 2023 | 24.98% |
| Mar 31, 2023 | 5.80% |
| Dec 31, 2022 | -30.99% |
| Sep 30, 2022 | 29.50% |
| Jun 30, 2022 | 9.60% |
| Mar 31, 2022 | 9.17% |
| Dec 31, 2021 | 4.25% |
| Sep 30, 2021 | 20.40% |
| Jun 30, 2021 | -1.41% |
| Mar 31, 2021 | -12.53% |